Chicago, Illinois. May 29, 2012 - GN Otometrics, the world leader in hearing and balance diagnostic systems, has been awarded a multi-year contract to supply newborn hearing screening (NHS) devices to the Ontario Infant Hearing Program (IHP). According to Dan McNulty, General Manager at GN Otometrics, "We are extremely pleased to be associated with IHP. This is an important step for the new MADSEN AccuScreen and builds on our legacy in the Americas. We look forward to the next steps, which include receiving FDA clearance and launching in the US market."
Each year in Ontario, approximately 300 children are born with, or acquire, permanent hearing impairment. IHP is a province-wide program that seeks to address the needs of these infants and their families. IHP currently uses nearly 700 newborn screening devices across 12 designated regions of Ontario to screen 130,000 babies each year. More than 200 units of the new AccuScreen devices have already been delivered. The Ontario Ministry selected the new AccuScreen based on its ability to perform in a wide variety of testing environments, ease of use, ergonomics, and excellent disposables.
Like its predecessor, the new AccuScreen is designed to meet requirements of NHS programs across the world, offering protocols that require OAE &/or ABR, selectable dB levels for ABR and a multiple ranges for OAE testing. The intuitive user interface and innovative full color touch-screen allows for fast training, a more efficient screening process while delivering the quality and accuracy expected from the AccuScreen name.
Copenhagen-based GN Otometrics is the world's leading manufacturer of hearing and balance instruments and software. The company has solutions ranging from infant-screening applications and audiologic diagnostics, to balance testing and hearing-instrument fitting. Visit www.otometrics.com for more information, or the Otometrics web channel on AudiologyOnline.
GN Otometrics Awarded Sole-Source NHS Contract in Ontario, Canada
Share:
